USA - NYSE:VTR - US92276F1003 - REIT
The current stock price of VTR is 74.98 USD. In the past month the price increased by 10.26%. In the past year, price increased by 15.09%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL | WELLTOWER INC | 128.52 | 124.64B | ||
| OHI | OMEGA HEALTHCARE INVESTORS | 23.13 | 12.69B | ||
| DOC | HEALTHPEAK PROPERTIES INC | 89.35 | 12.42B | ||
| ARE | ALEXANDRIA REAL ESTATE EQUIT | N/A | 9.42B | ||
| CTRE | CARETRUST REIT INC | 29.27 | 8.04B | ||
| AHR | AMERICAN HEALTHCARE REIT INC | N/A | 7.94B | ||
| HR | HEALTHCARE REALTY TRUST INC | N/A | 6.30B | ||
| DHCNL | DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 | N/A | 4.30B | ||
| SBRA | SABRA HEALTH CARE REIT INC | 23.95 | 4.36B | ||
| DHCNI | DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 | N/A | 4.11B | ||
| NHI | NATL HEALTH INVESTORS INC | 25.47 | 3.62B | ||
| MPW | MEDICAL PROPERTIES TRUST INC | N/A | 2.93B |
Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. The company is headquartered in Chicago, Illinois and currently employs 498 full-time employees. The firm holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The firm owns approximately 1,400 properties in North America and the United Kingdom. The company operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. The company engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs).
VENTAS INC
300 N Lasalle Street, Suite 1600
Chicago ILLINOIS 60654 US
CEO: Debra A. Cafaro
Employees: 498
Phone: 13126603800
Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. The company is headquartered in Chicago, Illinois and currently employs 498 full-time employees. The firm holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The firm owns approximately 1,400 properties in North America and the United Kingdom. The company operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. The company engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs).
The current stock price of VTR is 74.98 USD. The price increased by 0.08% in the last trading session.
VENTAS INC (VTR) has a dividend yield of 2.59%. The yearly dividend amount is currently 1.76.
VTR has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
VTR stock is listed on the New York Stock Exchange, Inc. exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on VTR.
VENTAS INC (VTR) has a market capitalization of 34.08B USD. This makes VTR a Large Cap stock.
ChartMill assigns a technical rating of 9 / 10 to VTR. When comparing the yearly performance of all stocks, VTR is one of the better performing stocks in the market, outperforming 75.6% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to VTR. VTR has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months VTR reported a non-GAAP Earnings per Share(EPS) of 0.52. The EPS increased by 425% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.28% | ||
| ROA | 0.88% | ||
| ROE | 1.87% | ||
| Debt/Equity | 0.98 |
25 analysts have analysed VTR and the average price target is 78.88 USD. This implies a price increase of 5.2% is expected in the next year compared to the current price of 74.98.
For the next year, analysts expect an EPS growth of 143.12% and a revenue growth 15.94% for VTR